Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization

Pancreatic cancer rapidly acquires resistance to chemotherapy resulting in its being difficult to treat. Gemcitabine is the current clinical chemotherapy strategy; however, owing to gemcitabine resistance, it is only able to prolong the life of patients with pancreatic cancer for a limited number of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Yan, Tao, Li, Hai-Ying, Wu, Jian-Song, Niu, Qiang, Duan, Wei-Hong, Han, Qing-Zeng, Ji, Wang-Ming, Zhang, Tao, Lv, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652142/
https://ncbi.nlm.nih.gov/pubmed/29098031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6836
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados